INMD logo

InMode (INMD) Stock

Profile

Sector:

Healthcare

Country:

Israel

IPO:

08 August 2019

Indexes:

Not included

Description:

InMode Ltd. is one of the world's leading manufacturers of equipment for innovative minimally invasive and non-invasive medical treatment technologies. Founded in 2008. Headquarters located in Yokneam, Israel. InMode's products are based on radiofrequency and laser technology, consisting of 8 basic workstations and grouped into 3 product segments: equipment for facial and body contouring, for aesthetic surgery, and for gynecology.

Events Calendar

Earnings

Next earnings date:

Feb 13, 2025

Recent quarterly earnings:

Oct 30, 2024

Recent annual earnings:

Feb 13, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Oct 01, 2021

Analyst ratings

Recent major analysts updates

31 Oct '24 Needham
Hold
21 Oct '24 Alliance Global Partners
Buy
17 Oct '24 BTIG
Buy
14 Oct '24 Barclays
Overweight
10 Oct '24 Needham
Hold
27 Sept '24 Raymond James
Outperform
22 Aug '24 Scotiabank
Sector Outperform
23 July '24 Jefferies
Hold
15 July '24 Barclays
Overweight
12 July '24 Canaccord Genuity
Hold

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Efficiency

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Institutional Ownership

InMode: Product Origination And Undervaluation Make The Stock A Buy
InMode: Product Origination And Undervaluation Make The Stock A Buy
InMode: Product Origination And Undervaluation Make The Stock A Buy
INMD
seekingalpha.com12 December 2024

InMode Ltd. demonstrates impressive net income growth from non-invasive surgical products, with new platforms Define and Envision expected to drive future business growth. The company's innovative technologies in plastic surgery, dermatology, gynecology, and ophthalmology, along with ongoing stock repurchases, make InMode a compelling buy. Strong financials show consistent income growth and significant cash flow, with minimal liabilities, indicating a robust financial position and undervaluation.

InMode to Present at Upcoming Investor Conferences
InMode to Present at Upcoming Investor Conferences
InMode to Present at Upcoming Investor Conferences
INMD
prnewswire.com06 November 2024

YOKNEAM, Israel , Nov. 6, 2024 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced the participation at the following investor conferences in November and December: UBS Global Healthcare Conference Presenters: Yair Malca, Chief Financial Officer Format: In-person fireside chat moderated by Danielle Antalffy, Senior Equity Analyst, and one-on-one meetings Location: Palos Verdes, CA When: Tuesday, Nov. 12 at 2:00 pm PT A live webcast of the presentation can be accessed here.

InMode: A Deep Dive After Q3 Earnings
InMode: A Deep Dive After Q3 Earnings
InMode: A Deep Dive After Q3 Earnings
INMD
seekingalpha.com31 October 2024

InMode's products are part of the medical aesthetics industry that is expected to grow at an 11% CAGR over the next five years. Despite a punishing macro environment of late that has seen its share price decline over 80% from its peak, InMode has remained profitable while continuing to innovate. The strong new and second-hand sales market for their platforms suggest their customers continue to see value in their products.

InMode Ltd. (INMD) Q3 2024 Earnings Call Transcript
InMode Ltd. (INMD) Q3 2024 Earnings Call Transcript
InMode Ltd. (INMD) Q3 2024 Earnings Call Transcript
INMD
seekingalpha.com30 October 2024

InMode Ltd. (NASDAQ:INMD ) Q3 2024 Earnings Conference Call October 30, 2024 8:30 AM ET Company Participants Miri Segal - CEO, MS-IR Moshe Mizrahy - Chief Executive Officer Michael Kreindel - Chief Technology Officer Yair Malca - Chief Financial Officer Eran Krieger - Medical Director and VP of Medical Affairs Rafael Lickerman - Vice President, Finance Conference Call Participants Matt Miksic - Barclays Caitlin Cronin - Canaccord Genuity Sam Eiber - BTIG Operator Good day, and welcome to the InMode's Third Quarter 2024 Earnings Results Conference Call.

InMode Reports Third Quarter 2024 Financial Results; Quarterly GAAP Revenue of $130.2 Million (which consists of $98.3 million of net sales in Q3 and $31.9 million of pre-orders from the first half of 2024)
InMode Reports Third Quarter 2024 Financial Results; Quarterly GAAP Revenue of $130.2 Million (which consists of $98.3 million of net sales in Q3 and $31.9 million of pre-orders from the first half of 2024)
InMode Reports Third Quarter 2024 Financial Results; Quarterly GAAP Revenue of $130.2 Million (which consists of $98.3 million of net sales in Q3 and $31.9 million of pre-orders from the first half of 2024)
INMD
prnewswire.com30 October 2024

YOKNEAM, Israel, Oct. 30, 2024 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, today announced its consolidated financial results for the third quarter ended September 30, 2024.

Earnings Preview: InMode (INMD) Q3 Earnings Expected to Decline
Earnings Preview: InMode (INMD) Q3 Earnings Expected to Decline
Earnings Preview: InMode (INMD) Q3 Earnings Expected to Decline
INMD
zacks.com23 October 2024

InMode (INMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

InMode to Report Third Quarter 2024 Financial Results and Hold Conference Call on October 30, 2024
InMode to Report Third Quarter 2024 Financial Results and Hold Conference Call on October 30, 2024
InMode to Report Third Quarter 2024 Financial Results and Hold Conference Call on October 30, 2024
INMD
prnewswire.com10 October 2024

Expects Q3 Revenue Between $130.0 Million -$130.1 Million (including $31.9 Million in Revenue from First Half of 2024 Pre-orders), Decreases Full Year 2024 Guidance to $410 Million-$420 Million Conference call to be held on Wednesday, October 30, 2024, at 8:30 a.m. Eastern Time YOKNEAM, Israel, Oct. 10, 2024 /PRNewswire/ -- InMode Ltd.

InMode Announces Departures of President of North America, Chief Medical Officer and VP of Sales USA as Part of a Global Reorganization Strategy
InMode Announces Departures of President of North America, Chief Medical Officer and VP of Sales USA as Part of a Global Reorganization Strategy
InMode Announces Departures of President of North America, Chief Medical Officer and VP of Sales USA as Part of a Global Reorganization Strategy
INMD
prnewswire.com01 October 2024

YOKNEAM, Israel , Oct. 1, 2024 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies today announced the departure of Shakil Lakhani, President of North America effective September 30, 2024.

Are Investors Undervaluing InMode (INMD) Right Now?
Are Investors Undervaluing InMode (INMD) Right Now?
Are Investors Undervaluing InMode (INMD) Right Now?
INMD
zacks.com10 September 2024

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

FAQ

  • What is the primary business of InMode?
  • What is the ticker symbol for InMode?
  • Does InMode pay dividends?
  • What sector is InMode in?
  • What industry is InMode in?
  • What country is InMode based in?
  • When did InMode go public?
  • Is InMode in the S&P 500?
  • Is InMode in the NASDAQ 100?
  • Is InMode in the Dow Jones?
  • When was InMode's last earnings report?
  • When does InMode report earnings?
  • Should I buy InMode stock now?

What is the primary business of InMode?

InMode Ltd. is one of the world's leading manufacturers of equipment for innovative minimally invasive and non-invasive medical treatment technologies. Founded in 2008. Headquarters located in Yokneam, Israel. InMode's products are based on radiofrequency and laser technology, consisting of 8 basic workstations and grouped into 3 product segments: equipment for facial and body contouring, for aesthetic surgery, and for gynecology.

What is the ticker symbol for InMode?

The ticker symbol for InMode is NASDAQ:INMD

Does InMode pay dividends?

No, InMode does not pay dividends

What sector is InMode in?

InMode is in the Healthcare sector

What industry is InMode in?

InMode is in the Medical Devices industry

What country is InMode based in?

InMode is headquartered in Israel

When did InMode go public?

InMode's initial public offering (IPO) was on 08 August 2019

Is InMode in the S&P 500?

No, InMode is not included in the S&P 500 index

Is InMode in the NASDAQ 100?

No, InMode is not included in the NASDAQ 100 index

Is InMode in the Dow Jones?

No, InMode is not included in the Dow Jones index

When was InMode's last earnings report?

InMode's most recent earnings report was on 30 October 2024

When does InMode report earnings?

The next expected earnings date for InMode is 13 February 2025

Should I buy InMode stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions